Page 22 - Slide 1
P. 22

Imaging Guidance: Prioritization of Oncology Patients




           •   Conduct “timed” imaging examinations during active phase of treatment
               (eg, assessment of response)
           •   Consider deferring surveillance imaging for recurrence



          Modality          Considerations
          CT and MRI        • Book per existing scheduling
                            • Patients with neo/adjuvant indications with modest survival benefits could be considered for deferral

          PET               • Perform imaging if new therapy is being considered
                            • Consider deferring in patients with relatively indolent malignancies that will not be treated or therapy
                               will not be altered during pandemic

          BMD               • To be deferred unless expressly requested by oncology

          Ultrasound        • Proceed as required for ongoing clinical management of cancer patients according to planning priority

          Interventional    • Proceed as required for ongoing clinical management of cancer patients according to planning priority
          Radiology         • Consider deferring prostate biopsy for non-high-risk patients


          Priority levels: A – deemed critical; B – cancer patients requiring systemic/radiation treatment; C – generally healthy, non-life-threatening condition).


     Ontario Health - Cancer Care Ontario: COVID-19 Supplemental Clinical Guidance for Patients with Cancer. March 29, 2020
                                                                                                                                             22
   17   18   19   20   21   22   23   24   25   26   27